S&P 500   4,520.45 (-1.24%)
DOW   34,452.88 (-0.54%)
QQQ   379.81 (-2.59%)
AAPL   161.12 (-1.61%)
MSFT   319.84 (-2.93%)
FB   300.82 (-3.08%)
GOOGL   2,813.40 (-1.61%)
AMZN   3,370.34 (-1.95%)
TSLA   1,014.66 (-6.45%)
NVDA   302.40 (-5.87%)
BABA   111.38 (-8.70%)
NIO   32.15 (-11.19%)
CGC   9.91 (-4.34%)
AMD   141.35 (-6.19%)
GE   92.56 (-2.80%)
MU   82.13 (-0.90%)
T   23.41 (+1.56%)
F   19.27 (-3.02%)
DIS   145.62 (-1.07%)
PFE   53.50 (+0.87%)
AMC   27.53 (-9.08%)
ACB   5.79 (-5.70%)
BA   196.71 (-2.80%)
S&P 500   4,520.45 (-1.24%)
DOW   34,452.88 (-0.54%)
QQQ   379.81 (-2.59%)
AAPL   161.12 (-1.61%)
MSFT   319.84 (-2.93%)
FB   300.82 (-3.08%)
GOOGL   2,813.40 (-1.61%)
AMZN   3,370.34 (-1.95%)
TSLA   1,014.66 (-6.45%)
NVDA   302.40 (-5.87%)
BABA   111.38 (-8.70%)
NIO   32.15 (-11.19%)
CGC   9.91 (-4.34%)
AMD   141.35 (-6.19%)
GE   92.56 (-2.80%)
MU   82.13 (-0.90%)
T   23.41 (+1.56%)
F   19.27 (-3.02%)
DIS   145.62 (-1.07%)
PFE   53.50 (+0.87%)
AMC   27.53 (-9.08%)
ACB   5.79 (-5.70%)
BA   196.71 (-2.80%)
S&P 500   4,520.45 (-1.24%)
DOW   34,452.88 (-0.54%)
QQQ   379.81 (-2.59%)
AAPL   161.12 (-1.61%)
MSFT   319.84 (-2.93%)
FB   300.82 (-3.08%)
GOOGL   2,813.40 (-1.61%)
AMZN   3,370.34 (-1.95%)
TSLA   1,014.66 (-6.45%)
NVDA   302.40 (-5.87%)
BABA   111.38 (-8.70%)
NIO   32.15 (-11.19%)
CGC   9.91 (-4.34%)
AMD   141.35 (-6.19%)
GE   92.56 (-2.80%)
MU   82.13 (-0.90%)
T   23.41 (+1.56%)
F   19.27 (-3.02%)
DIS   145.62 (-1.07%)
PFE   53.50 (+0.87%)
AMC   27.53 (-9.08%)
ACB   5.79 (-5.70%)
BA   196.71 (-2.80%)
S&P 500   4,520.45 (-1.24%)
DOW   34,452.88 (-0.54%)
QQQ   379.81 (-2.59%)
AAPL   161.12 (-1.61%)
MSFT   319.84 (-2.93%)
FB   300.82 (-3.08%)
GOOGL   2,813.40 (-1.61%)
AMZN   3,370.34 (-1.95%)
TSLA   1,014.66 (-6.45%)
NVDA   302.40 (-5.87%)
BABA   111.38 (-8.70%)
NIO   32.15 (-11.19%)
CGC   9.91 (-4.34%)
AMD   141.35 (-6.19%)
GE   92.56 (-2.80%)
MU   82.13 (-0.90%)
T   23.41 (+1.56%)
F   19.27 (-3.02%)
DIS   145.62 (-1.07%)
PFE   53.50 (+0.87%)
AMC   27.53 (-9.08%)
ACB   5.79 (-5.70%)
BA   196.71 (-2.80%)
NYSE:EVH

Evolent Health Stock Forecast, Price & News

$26.04
-0.58 (-2.18%)
(As of 12/3/2021 12:03 PM ET)
Add
Compare
Today's Range
$25.76
$26.58
50-Day Range
$25.36
$34.11
52-Week Range
$14.60
$34.60
Volume
12,317 shs
Average Volume
622,919 shs
Market Capitalization
$2.33 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.07
30 days | 90 days | 365 days | Advanced Chart
Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.


Evolent Health logo

About Evolent Health

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
2,900
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.02 billion
Cash Flow
$3.29 per share
Book Value
$7.34 per share

Profitability

Net Income
$-334.25 million
Pretax Margin
-5.32%

Debt

Price-To-Earnings

Miscellaneous

Free Float
85,656,000
Market Cap
$2.33 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
12/03/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/24/2022

MarketRank

Overall MarketRank

2.33 out of 5 stars

Computer And Technology Sector

257th out of 890 stocks

Management Services Industry

4th out of 9 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












Evolent Health (NYSE:EVH) Frequently Asked Questions

Is Evolent Health a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Evolent Health stock.
View analyst ratings for Evolent Health
or view top-rated stocks.

How has Evolent Health's stock price been impacted by Coronavirus?

Evolent Health's stock was trading at $6.92 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EVH shares have increased by 276.3% and is now trading at $26.04.
View which stocks have been most impacted by COVID-19
.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Evolent Health
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) issued its earnings results on Wednesday, November, 3rd. The technology company reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.08) by $0.05. Evolent Health had a negative trailing twelve-month return on equity of 3.60% and a negative net margin of 5.00%. During the same period last year, the firm earned ($0.07) earnings per share.
View Evolent Health's earnings history
.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its FY 2021 earnings guidance on Wednesday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $884 million-$900 million, compared to the consensus revenue estimate of $889.77 million.

What price target have analysts set for EVH?

5 Wall Street analysts have issued 12-month target prices for Evolent Health's shares. Their forecasts range from $25.00 to $50.00. On average, they anticipate Evolent Health's stock price to reach $36.60 in the next year. This suggests a possible upside of 40.6% from the stock's current price.
View analysts' price targets for Evolent Health
or view top-rated stocks among Wall Street analysts.

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:
  • Seth B. Blackley, Chief Executive Officer & Non-Independent Director
  • Steven Tutewohl, Chief Operating Officer (LinkedIn Profile)
  • John Johnson, Chief Financial Officer
  • John Tam, Chief Strategy Officer
  • Anita Cattrell, Chief Innovation Officer

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health CEO Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among Evolent Health's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Evolent Health's key competitors?

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Engaged Capital LLC (9.04%), BlackRock Inc. (6.42%), Granahan Investment Management Inc. MA (5.52%), Credit Suisse AG (4.36%), Dimensional Fund Advisors LP (3.79%) and Bellevue Group AG (3.48%). Company insiders that own Evolent Health stock include Cheryl Scott, Frank J Williams, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends for Evolent Health
.

Which major investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Engaged Capital LLC, Bellevue Group AG, Sectoral Asset Management Inc, Two Sigma Advisers LP, Segall Bryant & Hamill LLC, Peregrine Capital Management LLC, Credit Suisse AG, and BlackRock Inc.. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey, and Steve Tutewohl.
View insider buying and selling activity for Evolent Health
or view top insider-selling stocks.

Which major investors are buying Evolent Health stock?

EVH stock was bought by a variety of institutional investors in the last quarter, including TIG Advisors LLC, Islet Management LP, Rock Springs Capital Management LP, HAP Trading LLC, Invesco Ltd., Nordea Investment Management AB, EAM Global Investors LLC, and Tudor Investment Corp Et Al.
View insider buying and selling activity for Evolent Health
or or view top insider-buying stocks.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $26.04.

How much money does Evolent Health make?

Evolent Health has a market capitalization of $2.33 billion and generates $1.02 billion in revenue each year. The technology company earns $-334.25 million in net income (profit) each year or ($0.55) on an earnings per share basis.

How many employees does Evolent Health have?

Evolent Health employs 2,900 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

Where are Evolent Health's headquarters?

Evolent Health is headquartered at 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at (571) 389-6000, via email at [email protected], or via fax at 571-389-6001.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.